Pepsi Vs Coke Stock: Which Is Best?
Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…
Sell
42
DBVT Quote, Financials, Valuation and Earnings
Last price:
$4.84
Seasonality move
:
8.01%
Day range:
$4.73 - $5.09
52-week range:
$2.20 - $8.32
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.79x
Volume:
20.4K
Avg. volume:
25.2K
1-year change:
-38.64%
Market cap:
$96.9M
Revenue:
--
EPS (TTM):
-$5.25
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, DBV Technologies SA has 361.65% upside to fair value with a price target of $21.81 per share.
DBVT vs. S&P 500
-
Over the past 5 trading days, DBV Technologies SA has overperformed the S&P 500 by 9.69% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
DBV Technologies SA does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
DBV Technologies SA has grown year-over-year revenues for 0 quarters straight. In the most recent quarter DBV Technologies SA reported revenues of --.
Earnings Growth
-
DBV Technologies SA has grown year-over-year earnings for 0 quarters straight. In the most recent quarter DBV Technologies SA reported earnings per share of -$1.60.
Enterprise value:
51.2M
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
-0.47x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -$73M | -$102.5M | -$104.8M | -$18.3M | -$30.3M | |
| EBITDA | -$63.3M | -$83M | -$96.8M | -$15.7M | -$28.6M | |
| Diluted EPS | -$5.40 | -$5.50 | -$5.25 | -$0.85 | -$1.60 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $110.1M | $225.7M | $169.3M | $68.8M | |
| Total Assets | -- | $170.9M | $248.1M | $189.8M | $93.1M | |
| Current Liabilities | -- | $33.8M | $28.4M | $31.4M | $30.9M | |
| Total Liabilities | -- | $54M | $36.1M | $45.8M | $39M | |
| Total Equity | -- | $116.9M | $212.1M | $144M | $54M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$50.6M | -$89.9M | -$105.9M | -$19.6M | -$22.5M | |
| Cash From Investing | -$540K | -$655K | -$1.7M | -$322K | -$109K | |
| Cash From Financing | $194.8M | $6.7M | -$277K | -$837K | $7K | |
| Free Cash Flow | -$52.2M | -$90.2M | -$108.7M | -$19.6M | -$22.9M | |
DBVT
Sector
Market Cap
$96.9M
$37.4M
Price % of 52-Week High
56.81%
45.61%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.75%
1-Year Price Total Return
-38.64%
-38.36%
Beta (5-Year)
0.707
0.774
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$4.66
200-day SMA
Buy
Level
$4.11
Bollinger Bands (100)
Buy
Level
3.19 - 4.53
Chaikin Money Flow
Sell
Level
-46.8M
20-day SMA
Buy
Level
$4.43
Relative Strength Index (RSI14)
Buy
Level
55.49
ADX Line
Buy
Level
25.44
Williams %R
Neutral
Level
-38.8514
50-day SMA
Buy
Level
$4.33
MACD (12, 26)
Buy
Level
0.15
25-day Aroon Oscillator
Buy
Level
32
On Balance Volume
Neutral
Level
104.5M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Viaskin targets specific antigen-presenting immune cells in the skin, called Langerhans cells, that capture the antigen and migrate to the lymph node to activate the immune system without passage of the antigen into the bloodstream, minimizing systemic exposure in the body. Its main product candidate is Viaskin Peanut for the treatment of peanut-allergic patients.
Stock Forecast FAQ
In the current month, DBVT has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The DBVT average analyst price target in the past 3 months is $21.81.
-
Where Will DBV Technologies SA Stock Be In 1 Year?
According to analysts, the consensus estimate is that DBV Technologies SA share price will rise to $21.81 per share over the next 12 months.
-
What Do Analysts Say About DBV Technologies SA?
Analysts are divided on their view about DBV Technologies SA share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that DBV Technologies SA is a Sell and believe this share price will drop from its current level to $9.92.
-
What Is DBV Technologies SA's Price Target?
The price target for DBV Technologies SA over the next 1-year time period is forecast to be $21.81 according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is DBVT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for DBV Technologies SA is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of DBVT?
You can purchase shares of DBV Technologies SA via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase DBV Technologies SA shares.
-
What Is The DBV Technologies SA Share Price Today?
DBV Technologies SA was last trading at $4.84 per share. This represents the most recent stock quote for DBV Technologies SA. Yesterday, DBV Technologies SA closed at $4.73 per share.
-
How To Buy DBV Technologies SA Stock Online?
In order to purchase DBV Technologies SA stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
Stock Ideas
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Sell
48
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
52
RGC alert for Mar 19
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Sell
46
CVNA alert for Mar 19
Carvana [CVNA] is down 10.69% over the past day.
Buy
93
ESLT alert for Mar 19
Elbit Systems [ESLT] is up 10.52% over the past day.
